• Teva Buying Allergan Generics, Creating 'Market Behemoth'
    Thwarted in its attempt to acquire the generic and specialty pharmaceuticals company Mylan, the Israeli-based Teva will purchase Ireland-based Allergan Generics for $40.5 billion in an acquisition that executive and investors at both companies - if not consumers - are applauding.
  • Mitsubishi Shuts Production - But Not Sales - In U.S.
    Mitsubishi Motors is ending production of its Outlander Sport crossover SUV in the U.S. and will close its only plant here, in Normal, Ill., if it does not find a buyer. At a news conference in Japan this morning, president and COO Tetsuro Aikawa said the decision is "strictly due to dwindling output in recent years" and is not related to labor costs or foreign exchange rates, Reuters' Minami Funakoshi reports.
  • Campbell's Tossing Artificial Colors, Flavors By 2018
    "Soup Is Good Food," Campbell used to tell consumers. Now it wants them to think of it as a "Good For You" food company and, as part of that ongoing transformation, it said at a investor's meeting Wednesday that it would remove all artificial flavors and ingredients from it products by 2018.
  • Remedies Proposed For Soaring Drug Prices
    The escalating cost of pharmaceuticals is under both scrutiny and attack as a new study comparing pricing and effectiveness was announced and 118 physicians signed a letter urging grassroots advocacy.
  • CFPB Smacks Citibank For $700 Million Worth Of Deceptive Marketing
    The Consumer Financial Protection Bureau has ordered Citibank and some subsidiaries to refund an estimated $700 million to roughly seven million customers who were victims of "deceptive marketing..."
  • With Share Slipping, A&P Files For Bankruptcy Again
    A&P - which as The Great Atlantic & Pacific Tea Company was the Walmart of its day to mom and pop dry grocers, butchers and bakers eking out a living in tiny shops with limited selection - filed for Chapter 11 bankruptcy protection late Sunday.
  • Ford F-150 Deals: Sign Of Trouble Or Of Marketing?
    A story two days ago that Ford is offering discounts of more than $10,000 in some regions on its new aluminum-bodied F-150 pickup "to reverse a sales slump while it works to build inventory on dealer lots" has stirred up a lot of interest - including some "move along, there's nothing to see here but marketing at work" reactions.
  • Despite Carps and Quips, Amazon Claims Prime Day Victory
    Amazon's Prime Day sale was, according to widespread reports, trashed on social media for everything from product selection to website woes to the extent of the savings being proffered. But, as Amazon has proven over its 20-year history, its long-game strategy is to win by coming close to losing.
  • Amazon, Walmart (Et Al.) Lure Shoppers With 'Black Friday In July' Discounts
    Smack in the slack of summer doldrums - retail sales unexpectedly declined 0.3% in June and May's advance was downgraded to 1.0% from 1.2% - retailers are unveiling their inner "have I got a deal for you" personas today.
  • Chinese Firm Ready To Bid For Micron's Chips But Closing Could Be Difficult
    In what would amount to the most money shelled out by a Chinese company to acquire a foreign firm, Tsinghua Unigroup has reportedly prepared a $23 billion bid for Micron Technology, although the Boise, Idaho-based chipmaker says it has not received an offer yet. The Wall Street Journal broke the story late yesterday.
« Previous Entries